NA
Niagen Bioscience Inc (NAGE)
NASDAQ·Healthcare·Biotechnology
$4.85
-2.32%
Mkt Cap $394.80M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 4, 2026 | $31.70M | $33.84M | +6.74% | $0.02 | $0.03 | +50.00% | — | — |
| Q4 2025 Nov 4, 2025 | $31.10M | $33.99M | +9.27% | $0.01 | $0.05 | +233.33% | — | — |
| Q3 2025 Aug 6, 2025 | $30.76M | $31.12M | +1.15% | $0.02 | $0.04 | +100.00% | — | — |
| Q2 2025 May 7, 2025 | $27.07M | $30.48M | +12.58% | $0.02 | $0.04 | +100.00% | — | — |
| Q1 2025 Mar 4, 2025 | $26.77M | $29.13M | +8.78% | $0.02 | $0.03 | +50.00% | — | — |
| Q4 2024 Oct 31, 2024 | $24.03M | $25.58M | +6.44% | $0.01 | $0.02 | +100.00% | — | — |
| Q2 2024 Jun 30, 2024 | $23.32M | $22.74M | -2.51% | -$0.02 | -$0.00 | +99.00% | — | — |
| Q1 2024 Mar 31, 2024 | $23.48M | $22.15M | -5.63% | -$0.02 | -$0.01 | +67.30% | — | — |
| Q4 2023 Dec 31, 2023 | $20.81M | $21.20M | +1.84% | -$0.02 | $0.00 | +106.76% | — | — |
| Q3 2023 Sep 30, 2023 | $20.30M | $19.50M | -3.95% | -$0.03 | -$0.01 | +57.40% | — | — |
| Q2 2023 Jun 30, 2023 | $19.42M | $20.32M | +4.66% | -$0.04 | -$0.03 | +26.93% | — | — |
| Q1 2023 Mar 31, 2023 | — | $22.56M | — | — | -$0.03 | — | — | — |
| Q4 2022 Dec 31, 2022 | $19.41M | $21.00M | +8.20% | -$0.05 | -$0.02 | +58.80% | — | — |
| Q3 2022 Sep 30, 2022 | — | $17.06M | — | — | -$0.01 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | $16.73M | — | — | -$0.09 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | $17.26M | — | — | -$0.11 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | $17.76M | — | — | -$0.08 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | $17.31M | — | — | -$0.13 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | $17.70M | — | — | -$0.08 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $14.68M | — | — | -$0.12 | — | — | — |